Chen et al. reported that MYH9 significantly enhances the stemness of lung cancer cells (LCCs) by regulating the expression of cancer stem cell (CSC) markers, including CD44, SOX2, Nanog, CD133, and OCT4. The gene discussed is MYH9; the disease is cancer.